Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients
Phase of Trial: Phase I
Latest Information Update: 28 Jan 2014
Price : $35 *
At a glance
- Drugs GAL 101 (Primary)
- Indications Glaucoma
- Focus Adverse reactions
- Sponsors Merz Pharmaceuticals GmbH
- 28 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Dec 2013 New trial record
- 29 Nov 2013 Study status changed from recruiting to active, not recruiting.